INS and type 2 diabetes mellitus: Patients with Type 2 diabetes show failure of glucose-induced insulin secretion, which is characterized by a decrease in the first phase of glucose-induced insulin secretion, delayed hyperinsulinaemia and, latterly, failure of insulin synthesis.